Ayhan Gazi Kalaycı

Ayhan Gazi Kalaycı

Auto-generated profile, based on publicly available information

Ayhan Gazi Kalaycı

Department of Pediatric Gastroenterology, Hepatology and Nutrition, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Arab Journal of Gastroenterology
Verified
Journal Article
Closed access
FDFatma Demirbaş
Fatma Demirbaş
GÇGönül Çaltepe
Gönül Çaltepe
ACAtakan Comba
Atakan Comba
HAHasan Abbasguliyev
Hasan Abbasguliyev
NUNeval Yurttan Uyar
Neval Yurttan Uyar
AKAyhan Gazi Kalaycı
Ayhan Gazi Kalaycı

25 August 2019 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
FDFatma Demirbaş
Fatma Demirbaş
GÇGönül Çaltepe
Gönül Çaltepe
ACAtakan Comba
Atakan Comba
HAHasan Abbasguliyev
Hasan Abbasguliyev
NUNeval Yurttan Uyar
Neval Yurttan Uyar
AKAyhan Gazi Kalaycı
Ayhan Gazi Kalaycı

1 January 2021 in Pediatric Gastroenterology, Hepatology & Nutrition
Verified
Journal Article
Open access
PDF file
FDFatma Demirbaş
Fatma Demirbaş
MKMustafa Kaymazlı
Mustafa Kaymazlı
GÇGönül Çaltepe
Gönül Çaltepe
HAHasan Abbasguliyev
Hasan Abbasguliyev
AKAyhan Gazi Kalaycı
Ayhan Gazi Kalaycı
ABAhmet Bektaş
Ahmet Bektaş
Demirbaş F, et al. Pediatr Gastroenterol Hepatol Nutr. 2021 Mar;24(2):164-172. https://doi.org/10.5223/pghn.2021.24.2.164

1 December 2021 in Sao Paulo Medical Journal
Verified
Journal Article
Open access
FDFatma Demirbaş
Fatma Demirbaş
GÇGönül Çaltepe
Gönül Çaltepe
HAHasan Abbasguliyev
Hasan Abbasguliyev
AKAyhan Gazi Kalaycı
Ayhan Gazi Kalaycı
BACKGROUND: Gastritis consists of inflammation of the gastric mucosa and is one of the main causes of dyspeptic symptoms in children. OBJECTIVE: To investigate the presence of inflammation by evaluating fecal calprotectin (FC) in children diagnosed with chronic gastritis. DESIGN AND SETTING: Descriptive study in Pediatric Gastroenterology Department of Ondokuz Mayis University Hospital in Turkey. METHODS: Between January 2016 and July 2018, FC levels were compared retrospectively in children with chronic gastritis (histopathology-based diagnosis), patients with inflammatory bowel disease (IBD) and healthy children. RESULTS: A total of 67 chronic gastritis patients (61.2% girls) with a mean age of 13.09 +/- 3.5 years were evaluated. The mean FC levels were 153.4 mu g/g in the chronic gastritis group, 589.7 mu g/g in the IBD group and 43.8 mu g/g in the healthy group. These levels were higher in chronic gastritis patients than in healthy individuals (P = 0.001) and higher in IBD patients than in the other two groups (P < 0.001). The FC level in the patients with chronic active gastritis (156.3 mu g/g) was higher than in those with chronic inactive gastritis (150.95 mu g/g) (P = 0.011). Among the patients with chronic active gastritis, the FC level was significantly higher in Helicobacter pylori-positive individuals than in negative individuals (P = 0.031). CONCLUSION: We confirmed the association between increased FC and chronic gastritis. Elevated FC levels may be seen in patients with chronic active gastritis. In order to be able to use FC as a screening tool for chronic gastritis, further studies in a larger study group are needed.

1 January 2021 in Journal of Laparoendoscopic & Advanced Surgical Techniques
Verified
Journal Article
Closed access
FDFatma Demirbaş
Fatma Demirbaş
BDBerat Dilek Demirel
Berat Dilek Demirel
GÇGönül Çaltepe
Gönül Çaltepe
HAHasan Abbasguliyev
Hasan Abbasguliyev
RBRıza Ferit Bernay
Rıza Ferit Bernay
AKAyhan Gazi Kalayci
Ayhan Gazi Kalayci
Background: The aim of this study was to evaluate 24-hour pH monitoring results before and after gastrostomy in neurological impaired (NI) children who underwent gastrostomy or Nissen fundoplication (NF) concurrently with gastrostomy. Materials and Methods: Between March and December 2018, NI patients who had previously received pre- and postgastrostomy (Group 1) or gastrostomy + NF (Group 2) underwent pH monitoring pre- and postoperatively. Results: Twenty patients [12 males (60%) and the median age of 5.6 (14 months–14.7 years) years] with NI were followed up during the study period. When pre- and postgastrostomy weight and BMI z-scores were compared, the results were significantly higher in both groups after procedure (P = .043, P = .040, respectively). The clinical results of the patients after the operation showed improvement in both groups. The pH index of Group 1 (n = 11) was 2.32 (0–3.8) before gastrostomy and 3.18 (2.1–6.9) after gastrostomy (P = .061) and in Group 2 (n = 9) it was 5.85 (4.9–15.8) and 0.61 (0.3–1.3), before and after procedure (P < .001). There was a statistically significant difference in reflux index of each group. This difference was not statistically significant between the groups (P = .072). When the total bolus exposure index was compared, it was 4.01 (2.1–5.2) before gastrostomy and 5.67 (4.6–6.3) after gastrostomy in Group 1 (P = .041). In group 2, that index was found to be 9.8 (8.3–10.2) before and 1.28 (0.5–1.4) after (P < .001). There was a statistically significant difference in index after gastrostomy in Groups 1 and 2 (P = .023). Conclusions: Gastrostomy feeding is an effective and safe option to achieve enteral feeding in NI children. NF concurrent with gastrostomy should be decided according to the individual patient. Clinical trials protocol registration ID number was PRS NCT 0445112.

5 January 2021 in Kocaeli Üniversitesi Sağlık Bilimleri Dergisi
Verified
Journal Article
Closed access
PDF file
FDFatma Demi̇rbaş
Fatma Demi̇rbaş
ASAslıhan Sanrı
Aslıhan Sanrı
GÇGönül Di̇nler Çaltepe
Gönül Di̇nler Çaltepe
ACAtakan Comba
Atakan Comba
AKAyhan Gazi Kalayci
Ayhan Gazi Kalayci
Amaç: Çölyak hastalığı (ÇH), genetik yatkınlığı olan bireylerde, glutene kalıcı duyarlılık sonucu gelişen, otoimmün, sistemik hastalıktır. Bu çalışmanın amacı, ÇH’nin klinik, laboratuar özellikleri ve HLA doku tiplerinin geriye dönük değerlendirilmesidir.Ayrıca lieratür taramasıyla HLA doku tipleri açısından Türkiye’de bölgelere göre farklılık ve benzerliklerin incelenmesidir. Yöntem: Çalışmaya, Temmuz 2017- Ekim 2018 tarihleri arasında ÇH tanısıyla izlenen ve genetik çalışması uygulanan 104 çocuk alındı. Google Scholarda Türkiye’de ÇH ve HLA genotiplendirme ile yapılan çalışmalar tarandı (n=11 çalışma) ve bölgelere ayrıldı. Bulgular: Çalışmaya alınan 104 hastanın 67’si kız (%64,4) ve ortalama tanı yaşı 7,9±2,38 yıl(10ay-17,2yıl) idi. Hastalarımızın HLA grupları %59,6 DQ2, %26,9 DQ8 ve %13,4 DQ2+DQ8 saptandı. Literatürdeki çalışmalar bölgeler göre değerlendirildiğinde bizim de içinde bulunduğumuz Karadeniz bölgesinde HLADQ2 %63,7 ve HLADQ8 %21,1 sıklıkla görülürken, bölgemize benzer oranlarda genotip sıklığı Akdeniz ve Doğu Anadolu bölgelerinde görülmektedir. İç Anadolu HLADQ2 %87,4 ve Marmara bölgesinde %83,6 ile daha yüksek frekansta görülmektedir. Çalışmamızda, DQA1*05 %65,4 ve DQB1*02 %12,5 oranında bulundu. Türkiye’deki diğer çalışmalarda (Marmara, Karadeniz, İç, Doğu ve Güneydoğu Anadolu Bölgeleri) görülme sıklığı DQA1*05%69,8 ve DQB1*02 %27,7 idi. Çalışmamızda HLA DQB1*02 homozigot olan hastalarda (%12,5) boy kısalığı, ishal, demir eksikliği anemisi, Marsh3 evre ve akrabalarında ÇH daha yüksekti. Sonuç: Çölyak hastalığında HLA-DQ analizi bölgesel sıklığın belirlenmesi genetik analiz maliyetini azaltmak ve bölgesel dağılıma göre özellikle semptomsuz tarama hastalarında genotiplenme yapılması erken tanı kolaylığı sağlayabilir.